Stories

Once known as the most progressive country on vaping and tobacco harm reduction, the UK is now poised to join the ranks of nations that demonize, restrict, ban, and tax, potentially lifesaving nicotine vaping products. Why is the UK turning its back on tobacco harm reduction?

Indonesia, known for its high smoking rate, approved vaping as a tobacco alternative in 2018. With a vast population of 280 million, the country faces critical tobacco harm issues and a high smoking rate of 34.5% among adults. Despite calls for a vape ban, the government opted for regulation. Supporters argue for regulation as a balanced approach that generates tax revenue, promotes smoking cessation, and protects human rights. Vape bans in Southeast Asia, including in ASEAN countries, have resulted in growing illicit markets. Emphasizing the importance of regional coordination and tailored regulations to local norms, a shift towards promoting safer alternatives to tobacco is crucial for Indonesia's public health concerns.

Several safer alternatives to cigarettes, like vapes, heat-not-burn products, snus, and nicotine pouches, are not being effectively promoted. Instead, political actions are making them less appealing, more costly, and harder to access. The letter urges Health Canada to rethink its approach to these products, emphasizing that millions of lives could be saved.

Dr. Nesheiwat, a Fox News medical contributor and CityMD medical director, is praised by Trump for her dedication to preventive medicine and public health. However, vaping advocates may question her suitability for Surgeon General due to her 2019 warning about vaping, which inaccurately linked nicotine e-cigarettes to lung illnesses later tied to black-market THC vapes. Her stance contributed to early fears about vaping's safety.

The text discusses the challenges faced by reduced-risk nicotine products amidst anti-smoking campaigns. Despite their success in lowering smoking rates, these alternatives face suspicion and bans in many countries. The tobacco control movement's resistance to harm reduction strategies is attributed to a reluctance to adapt and a fear of losing power. Endgame policies focusing on prohibitive measures have unintended consequences, while countries legalizing alternatives like vapes have seen significant reductions in smoking rates. The debate highlights a clash between harm reduction and prohibitionist approaches in tobacco control.

E-cigarette sales surged between 2019-2023, with 80% in youth-friendly flavors like fruit, candy, mint, and menthol. The CDC Foundation and Truth Initiative report highlighted the need for states to restrict flavored vape sales, citing successful efforts in Massachusetts. Sales of disposable e-cigarettes among young users rose over 500%, with most using flavored varieties. Nicotine levels in vapes reached that of several cigarette cartons, leading to increased youth addiction. The report emphasized the urgency for stricter policies to combat the flavored e-cigarette epidemic in the U.S. Proactive regulatory actions were called for to protect youth from the dangers of e-cigarettes.

The American Cancer Society's Great American Smokeout, now focusing on anti-vaping, has shifted its mission. Health groups misconstrue facts, discouraging safer alternatives to smoking. This misleads the public, neglecting harm reduction strategies. The campaign should prioritize saving lives over promoting a nicotine-free agenda. Misinformation surrounds vaping, dismissing its efficacy as a smoking cessation tool. Public health organizations should support all methods of quitting smoking, including vaping, as long as individuals receive proper assistance. The focus should be on improving health outcomes and reducing tobacco-related harms, especially in marginalized communities.

Community pharmacies in Medway, Kent, are participating in a smoking cessation pilot using e-cigarettes as quit aids. Seven pharmacies offer a locally commissioned service with vouchers for starter kits and vape liquids. The pilot aims to support England's goal of becoming smoke-free by 2030, targeting a 50% yearly quit attempt rate. Results from a Cochrane review indicate e-cigarettes, varenicline, and cytisine are effective in long-term smoking cessation. Emphasizing the importance of addressing health and economic disparities, the initiative involves community pharmacies to accelerate smoking reduction. Varenicline will be reintroduced for NHS patients following a safety recall in 2021.

Health groups in Scotland are urging the Scottish Government to implement a new tax on supermarkets selling alcohol and tobacco. The tax aims to raise funds for treatment and reduce health risks associated with these products. The Non-Communicable Diseases Alliance Scotland proposes a "public health supplement" on retailers, highlighting the significant costs to the economy and healthcare system. This measure could generate around £60 million annually. Advocates emphasize the need for industry accountability, supporting programs for healthier communities and early disease detection. Retailers oppose additional taxes, citing existing financial burdens. The Scottish Government is considering the proposal ahead of the Budget announcement.

Researchers connected symptoms of Parkinson’s disease and nicotine withdrawal through cholinergic interneurons in the brain's striatum. They found that inhibiting these neurons helped ease both conditions. A study using a mouse model altered with inhibited neurons showed reduced tremors during nicotine withdrawal. Repurposing the Parkinson's drug procyclidine also alleviated withdrawal symptoms, even boosting mobility. Further research will explore potential drug combinations for more effective smoking cessation treatments. This discovery offers a promising approach, linking Parkinson's treatment to nicotine withdrawal relief.